FamiCord AG
OTC: VTIAF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jakub Julian Baran
- Employees
- 771
- Headquarters
- Leipzig, Germany
- IPO year
- 2014
- Market cap
- $111.1M
- Website
- http://www.vita34.de
Loading VTIAF…
Loading profile data…Frequently asked questions about VTIAF
What does FamiCord AG (VTIAF) do?
FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. It also engages in the development of products and drugs derived from cells, tissues, and blood for medical applications. A...
Where does VTIAF trade?
FamiCord AG (VTIAF) trades on the Other OTC.
What sector is VTIAF in?
FamiCord AG (VTIAF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of FamiCord AG?
Jakub Julian Baran is the chief executive officer of FamiCord AG (VTIAF).
Where is FamiCord AG headquartered?
FamiCord AG is headquartered in Germany.
Does VTIAF pay a dividend?
FamiCord AG (VTIAF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VTIAF go public?
FamiCord AG (VTIAF) completed its initial public offering in 2014.